Sham tDCS
7
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Combination of Neurostimulation and Psychotherapy to Stop Worrying
tdCS Combined With Treadmill Training in Patients With Multiple Sclerosis
Supporting Decisions With Transcranial Direct Current Stimulation in Healthy Young and Elderly Individuals
tDCS to Prevent Relapse in Alcohol Use Disorder
Neuromodulation Augmented Cognitive Training to Improve Cognitive Flexibility in Anorexia Nervosa
Combining tDCS With VR-based Motor Training in Stroke
Combining Non-Invasive Brain Stimulation With Cognitive Behavioral Intervention in Substance Use Disorder